Guinea vs Syria: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guinea
2.8%
in 2024
Syria
2.9%
in 2024
Guinea rank
8th
Syria rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guinea
- Syria
How they compare
Syria currently reports 2.9% against 2.8% in Guinea, a difference of 0.1%.
Across all 10 years both countries report, Syria has been ahead every year.
Guinea ranks 8th and Syria ranks 6th of 247 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 3.5% | 0.7% | Syria |
| 2020s | 2.7% | 3.4% | 0.7% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guinea or Syria?
- Syria, at 2.9% against 2.8% in Guinea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guinea and Syria?
- 0.1%, with Syria ahead.
- How many years of comparable data are there for Guinea and Syria?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Syria rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guinea ranks 8th and Syria ranks 6th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.